Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Why Shares of UroGen Pharma Jumped Friday
Jim Halley
|
Jul 28, 2023
The company released positive top-line results for two studies for a bladder cancer treatment.
Why Shares of Phathom Pharmaceutical Jumped This Week
Jim Halley
|
Jan 28, 2023
Investors are reading between the lines to see if the company is fixing its problems regarding its lead therapy.
Why Nektar Therapeutics Stock Is Crashing Today
Keith Speights
|
Apr 18, 2022
The company is throwing in the towel on its lead pipeline program.
Why Nektar Therapeutics Stock Is Imploding Today
Cory Renauer
|
Mar 14, 2022
A clinical trial readout involving the company's lead candidate didn't produce the results investors were hoping for.
Why Bolt Biotherapeutics Stock Crashed Today
Keith Speights
|
Dec 6, 2021
The company announced disappointing interim data from a phase 1/2 study of its lead cancer program.
Why Nektar Therapeutics Stock Plunged Today
Keith Speights
|
Nov 5, 2021
The company's Q3 revenue was lower than expected.
Nektar Therapeutics (NKTR) Q3 2021 Earnings Call Transcript
Motley Fool Transcribers
|
Nov 4, 2021
NKTR earnings call for the period ending September 30, 2021.
Nektar Therapeutics (NKTR) Q2 2021 Earnings Call Transcript
Motley Fool Transcribers
|
Aug 5, 2021
NKTR earnings call for the period ending June 30, 2021.
Nektar Therapeutics (NKTR) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
|
May 7, 2021
NKTR earnings call for the period ending March 31, 2021.
Nektar Therapeutics (NKTR) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
|
Feb 26, 2021
NKTR earnings call for the period ending December 31, 2020.
View More Articles